| Evidence for shared susceptibility in bipolar disorder and schizophrenia |
|
|
|
|
|
|
|
|
|
| Epigenetics and bipolar disorder: New opportunities and challenges |
|
|
|
|
|
|
|
|
|
| Heterogeneity and the genetics of bipolar disorder |
|
|
|
|
|
|
|
|
|
| Pharmacogenetics and mood stabilization in bipolar disorder |
|
|
|
|
|
|
|
|
|
| Studies of offspring of parents with bipolar disorder |
|
|
|
|
|
|
|
|
|
| Genetic linkage and association studies in bipolar affective disorder: A time for optimism |
|
|
|
|
|
|
|
|
|
| Anticipation and repeat expansion in bipolar disorder |
|
|
|
|
|
|
|
|
|
| Family, twin, and adoption studies of bipolar disorder |
|
|
|
|
|
|
|
|
|
| The neurobiology of bipolar disorder |
|
|
|
|
|
|
|
|
|
| Medical genetic studies in the Amish: Historical perspective |
|
|
|
|
|
|
|
|
|
| Pediatric medicine and the genetic disorders of the Amish and Mennonite people of Pennsylvania |
|
|
|
|
|
|
|
|
|
| Genetic heritage of the Old Order Mennonites of southeastern Pennsylvania |
|
|
|
|
|
|
✓ |
✓ |
Swiss; Switzerland; Swiss Mennonites |
| Anabaptist genealogy database |
|
|
|
|
|
|
|
|
|
| A study of linkage and association of body mass index in the old order Amish |
|
|
|
|
|
|
|
|
|
| The major mutation in the <i>RMRP</i> gene causing CHH among the Amish is the same as that found in most Finnish cases |
|
|
|
|
|
|
✓ |
✓ |
Old Order Amish; Amish; Finns; Finnish |
| Type I glutaric aciduria, part 1: Natural history of 77 patients |
|
|
|
|
|
|
✓ |
✓ |
Amish and non-Amish communities |
| Type I glutaric aciduria, part 2: A model of acute striatal necrosis |
|
|
|
|
|
|
|
|
|
| Communication about carrier testing within hemophilia A families |
|
|
|
|
|
|
|
|
|
| Disclosure, confidentiality, and families: Experiences and attitudes of those with genetic versus nongenetic medical conditions |
|
|
|
|
|
|
|
|
|
| Perceptions of reproductive risk and carrier testing among adolescent sisters of males with chronic granulomatous disease |
|
|
|
|
|
|
|
|
|
| Communication of <i>BRCA1</i> and <i>BRCA2</i> results to at‐risk relatives: A cancer risk assessment program's experience |
|
|
|
|
|
|
|
|
|
| Genetic testing and the family |
|
|
|
|
|
|
|
|
|
| How families communicate about HNPCC genetic testing: Findings from a qualitative study |
|
|
|
|
|
|
|
|
|
| Breast cancer survivors' attitudes about communication of breast cancer risk to their children |
|
✓ |
|
|
|
|
|
|
|
| Social and familial context of prenatal genetic testing decisions: Are there racial/ethnic differences? |
|
|
|
|
|
|
|
|
|
| Mental deficiency, alterations in performance, and CNS abnormalities in Overgrowth syndromes |
|
|
|
|
|
|
|
|
|
| Diagnostic evaluation of developmental delay/mental retardation: An overview |
|
|
|
|
|
|
|
|
|
| Advances in molecular cytogenetics for the evaluation of mental retardation |
|
|
|
|
|
|
|
|
|
| Metabolic disorders and mental retardation |
|
|
|
|
|
|
|
|
|
| Costello syndrome: An overview |
|
|
|
|
|
|
|
|
|